Nabi Biopharmaceuticals - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Nabi Biopharmaceuticals. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Nabi Biopharmaceuticals. The Group's principal activities are to discover, develop, manufacture and market vaccines and antibody based biopharmaceutical products. The Group operates in two segments: Biopharmaceutical products and Antibody products. The Biopharmaceutical products segment includes the production and sale of proprietary biopharmaceutical products, as well as research and development efforts for the biopharmaceutical product line. The Antibody products segment includes the collection and sale of non-specific and specialty antibody products to other biopharmaceutical manufacturers, as well as the production and sale of antibody-body control and diagnostic products and laboratory testing services. The Group operates in the United States, South Korea, Israel and Canada.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report